{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:16:28Z","timestamp":1788423388614,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,3]]},"DOI":"10.7759\/cureus.115698","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:03:02Z","timestamp":1788422582000},"source":"Crossref","is-referenced-by-count":0,"title":["A Narrative Review of Airway and Gut Microbiota in Chronic Obstructive Pulmonary Disease: Clinical Associations, Methodological Heterogeneity, and Translational Priorities"],"prefix":"10.7759","author":[{"given":"Ahmet","family":"Akcan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. (2025). Accessed. August 28, 2026: https:\/\/goldcopd.org\/wp-content\/uploads\/2026\/01\/GOLD-REPORT-2026-v1.3-8Dec2025_WMV2.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008578","article-title":"Disordered microbial communities in asthmatic airways","volume":"5","author":"Hilty M","year":"2010","unstructured":"Hilty M, Burke C, Pedro H, et al.. Disordered microbial communities in asthmatic airways. PLoS One. 2010, 5:e8578. 10.1371\/journal.pone.0008578","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016384","article-title":"Analysis of the lung microbiome in the \"healthy\" smoker and in COPD","volume":"6","author":"Erb-Downward JR","year":"2011","unstructured":"Erb-Downward JR, Thompson DL, Han MK, et al.. Analysis of the lung microbiome in the \"healthy\" smoker and in COPD. PLoS One. 2011, 6:e16384. 10.1371\/journal.pone.0016384","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201111-2075OC","article-title":"The lung tissue microbiome in chronic obstructive pulmonary disease","volume":"185","author":"Sze MA","year":"2012","unstructured":"Sze MA, Dimitriu PA, Hayashi S, et al.. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012, 185:1073-80. 10.1164\/rccm.201111-2075OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00035-14","article-title":"Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease","volume":"52","author":"Huang YJ","year":"2014","unstructured":"Huang YJ, Sethi S, Murphy T, Nariya S, Boushey HA, Lynch SV. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. J Clin Microbiol. 2014, 52:2813-23. 10.1128\/JCM.00035-14","journal-title":"J Clin Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01406-2015","article-title":"Lung microbiome dynamics in COPD exacerbations","volume":"47","author":"Wang Z","year":"2016","unstructured":"Wang Z, Bafadhel M, Haldar K, et al.. Lung microbiome dynamics in COPD exacerbations. Eur Respir J. 2016, 47:1082-92. 10.1183\/13993003.01406-2015","journal-title":"Eur Respir J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-210408","article-title":"Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations","volume":"73","author":"Mayhew D","year":"2018","unstructured":"Mayhew D, Devos N, Lambert C, et al.. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax. 2018, 73:422-30. 10.1136\/thoraxjnl-2017-210408","journal-title":"Thorax"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202009-3448OC","article-title":"Inflammatory endotype-associated airway microbiome in chronic obstructive pulmonary disease clinical stability and exacerbations: a multicohort longitudinal analysis","volume":"203","author":"Wang Z","year":"2021","unstructured":"Wang Z, Locantore N, Haldar K, et al.. Inflammatory endotype-associated airway microbiome in chronic obstructive pulmonary disease clinical stability and exacerbations: a multicohort longitudinal analysis. Am J Respir Crit Care Med. 2021, 203:1488-502. 10.1164\/rccm.202009-3448OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1173614","article-title":"The gut microbiome as a potential source of non-invasive biomarkers of chronic obstructive pulmonary disease","volume":"14","author":"Li N","year":"2023","unstructured":"Li N, Yi X, Chen C, et al.. The gut microbiome as a potential source of non-invasive biomarkers of chronic obstructive pulmonary disease. Front Microbiol. 2023, 14:1173614. 10.3389\/fmicb.2023.1173614","journal-title":"Front Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-022-01928-8","article-title":"Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study","volume":"23","author":"Chiu YC","year":"2022","unstructured":"Chiu YC, Lee SW, Liu CW, Lan TY, Wu LS. Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study. Respir Res. 2022, 23:10. 10.1186\/s12931-022-01928-8","journal-title":"Respir Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.12.810","article-title":"The gut microbiome is a significant risk factor for future chronic lung disease","volume":"151","author":"Liu Y","year":"2023","unstructured":"Liu Y, Teo SM, M\u00e9ric G, et al.. The gut microbiome is a significant risk factor for future chronic lung disease. J Allergy Clin Immunol. 2023, 151:943-52. 10.1016\/j.jaci.2022.12.810","journal-title":"J Allergy Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.106099","article-title":"Characterisation of the gut-lung axis microbiome in clinically stable patients with chronic obstructive pulmonary disease","volume":"123","author":"Viglino J","year":"2026","unstructured":"Viglino J, Perea L, Garcia-Nu\u00f1ez M, et al.. Characterisation of the gut-lung axis microbiome in clinically stable patients with chronic obstructive pulmonary disease. EBioMedicine. 2026, 123:106099. 10.1016\/j.ebiom.2025.106099","journal-title":"EBioMedicine"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19701-0","article-title":"Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease","volume":"11","author":"Bowerman KL","year":"2020","unstructured":"Bowerman KL, Rehman SF, Vaughan A, et al.. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nat Commun. 2020, 11:5886. 10.1038\/s41467-020-19701-0","journal-title":"Nat Commun"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202303-0489OC","article-title":"Loss of airway phylogenetic diversity is associated with clinical and pathobiological markers of disease development in chronic obstructive pulmonary disease","volume":"210","author":"Opron K","year":"2024","unstructured":"Opron K, Begley LA, Erb-Downward JR, et al.. Loss of airway phylogenetic diversity is associated with clinical and pathobiological markers of disease development in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2024, 210:186-200. 10.1164\/rccm.202303-0489OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-021-00185-9","article-title":"Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort","volume":"7","author":"Opron K","year":"2021","unstructured":"Opron K, Begley LA, Erb-Downward JR, et al.. Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort. NPJ Biofilms Microbiomes. 2021, 7:14. 10.1038\/s41522-021-00185-9","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-022-02246-9","article-title":"Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study","volume":"23","author":"Li W","year":"2022","unstructured":"Li W, Wang B, Tan M, Song X, Xie S, Wang C. Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study. Respir Res. 2022, 23:321. 10.1186\/s12931-022-02246-9","journal-title":"Respir Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.719541","article-title":"Sputum bacterial metacommunities in distinguishing heterogeneity in respiratory health and disease","volume":"13","author":"Si J","year":"2022","unstructured":"Si J, Choi Y, Raes J, Ko G, You HJ. Sputum bacterial metacommunities in distinguishing heterogeneity in respiratory health and disease. Front Microbiol. 2022, 13:719541. 10.3389\/fmicb.2022.719541","journal-title":"Front Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-024-02802-5","article-title":"Bacterial interactome disturbance in chronic obstructive pulmonary disease clinical stability and exacerbations","volume":"25","author":"Xiao W","year":"2024","unstructured":"Xiao W, Chen YL, Du LY, et al.. Bacterial interactome disturbance in chronic obstructive pulmonary disease clinical stability and exacerbations. Respir Res. 2024, 25:173. 10.1186\/s12931-024-02802-5","journal-title":"Respir Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-025-03471-8","article-title":"Longitudinal change of lung microbiome in chronic obstructive pulmonary disease: a prospective cohort study","volume":"27","author":"Moon SW","year":"2026","unstructured":"Moon SW, Kim M, Kim EY, et al.. Longitudinal change of lung microbiome in chronic obstructive pulmonary disease: a prospective cohort study. Respir Res. 2026, 27:152. 10.1186\/s12931-025-03471-8","journal-title":"Respir Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03278-x","article-title":"Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices","volume":"20","author":"Su L","year":"2022","unstructured":"Su L, Qiao Y, Luo J, et al.. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices. J Transl Med. 2022, 20:76. 10.1186\/s12967-022-03278-x","journal-title":"J Transl Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1386201","article-title":"Microbiome-host interactions in the pathogenesis of acute exacerbation of chronic obstructive pulmonary disease","volume":"14","author":"Li Y","year":"2024","unstructured":"Li Y, Mao X, Shi P, et al.. Microbiome-host interactions in the pathogenesis of acute exacerbation of chronic obstructive pulmonary disease. Front Cell Infect Microbiol. 2024, 14:1386201. 10.3389\/fcimb.2024.1386201","journal-title":"Front Cell Infect Microbiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2026.01.004","article-title":"Comparative analysis of clinical outcomes and short-term treatment response of sputum microbiome between eosinophilic and non-eosinophilic COPD acute exacerbation","author":"Liu T","year":"2026","unstructured":"Liu T, Lai CH, Wu YW, et al.. Comparative analysis of clinical outcomes and short-term treatment response of sputum microbiome between eosinophilic and non-eosinophilic COPD acute exacerbation. J Microbiol Immunol Infect. 2026, 10.1016\/j.jmii.2026.01.004","journal-title":"J Microbiol Immunol Infect"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00061-2024","article-title":"Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis\/mycoses","volume":"63","author":"Agarwal R","year":"2024","unstructured":"Agarwal R, Sehgal IS, Muthu V, et al.. Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis\/mycoses. Eur Respir J. 2024, 63:2400061. 10.1183\/13993003.00061-2024","journal-title":"Eur Respir J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02050-2020","article-title":"A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD","volume":"57","author":"Tiew PY","year":"2021","unstructured":"Tiew PY, Dicker AJ, Keir HR, et al.. A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD. Eur Respir J. 2021, 57:2002050. 10.1183\/13993003.02050-2020","journal-title":"Eur Respir J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1733726","article-title":"The gut-lung axis in COPD: immunomodulatory roles of gut microbiota and novel therapeutic strategies","volume":"17","author":"Ni FX","year":"2026","unstructured":"Ni FX, Wang HX, Hu J, et al.. The gut-lung axis in COPD: immunomodulatory roles of gut microbiota and novel therapeutic strategies. Front Immunol. 2026, 17:1733726. 10.3389\/fimmu.2026.1733726","journal-title":"Front Immunol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107635","article-title":"Differences in the gut and pharyngeal microbiomes before and after treatment of an acute exacerbation of chronic obstructive pulmonary disease","volume":"205","author":"Hu J","year":"2025","unstructured":"Hu J, Liu J, Wu H, Zhao T, Li Z, Luo J. Differences in the gut and pharyngeal microbiomes before and after treatment of an acute exacerbation of chronic obstructive pulmonary disease. Microb Pathog. 2025, 205:107635. 10.1016\/j.micpath.2025.107635","journal-title":"Microb Pathog"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202110-2241OC","article-title":"Lung microbiota and metabolites collectively associate with clinical outcomes in milder stage chronic obstructive pulmonary disease","volume":"206","author":"Madapoosi SS","year":"2022","unstructured":"Madapoosi SS, Cruickshank-Quinn C, Opron K, et al.. Lung microbiota and metabolites collectively associate with clinical outcomes in milder stage chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2022, 206:427-39. 10.1164\/rccm.202110-2241OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04287-23","article-title":"Gut virome alterations in patients with chronic obstructive pulmonary disease","volume":"12","author":"Liu Y","year":"2024","unstructured":"Liu Y, Huang Q, Zhuang Z, et al.. Gut virome alterations in patients with chronic obstructive pulmonary disease. Microbiol Spectr. 2024, 12:e0428723. 10.1128\/spectrum.04287-23","journal-title":"Microbiol Spectr"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00035-5","article-title":"Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis","volume":"2","author":"Ramsheh MY","year":"2021","unstructured":"Ramsheh MY, Haldar K, Esteve-Codina A, et al.. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis. Lancet Microbe. 2021, 2:e300-10. 10.1016\/S2666-5247(21)00035-5","journal-title":"Lancet Microbe"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06986-2","article-title":"Airway microbiota and immunity associated with chronic obstructive pulmonary disease severity","volume":"23","author":"Lin Z","year":"2025","unstructured":"Lin Z, Jiang Y, Liu H, et al.. Airway microbiota and immunity associated with chronic obstructive pulmonary disease severity. J Transl Med. 2025, 23:962. 10.1186\/s12967-025-06986-2","journal-title":"J Transl Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03860-22","article-title":"Genetic adaptation and acquisition of macrolide resistance in Haemophilus spp. during persistent respiratory tract colonization in chronic obstructive pulmonary disease (COPD) patients receiving long-term azithromycin treatment","volume":"11","author":"Carrera-Salinas A","year":"2023","unstructured":"Carrera-Salinas A, Gonz\u00e1lez-D\u00edaz A, Ehrlich RL, et al.. Genetic adaptation and acquisition of macrolide resistance in Haemophilus spp. during persistent respiratory tract colonization in chronic obstructive pulmonary disease (COPD) patients receiving long-term azithromycin treatment. Microbiol Spectr. 2023, 11:e0386022. 10.1128\/spectrum.03860-22","journal-title":"Microbiol Spectr"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202102-0289OC","article-title":"Effects of inhaled corticosteroid\/long-acting \u03b22-agonist combination on the airway microbiome of patients with chronic obstructive pulmonary disease: a randomized controlled clinical trial (DISARM)","volume":"204","author":"Leitao Filho FS","year":"2021","unstructured":"Leitao Filho FS, Takiguchi H, Akata K, et al.. Effects of inhaled corticosteroid\/long-acting \u03b22-agonist combination on the airway microbiome of patients with chronic obstructive pulmonary disease: a randomized controlled clinical trial (DISARM). Am J Respir Crit Care Med. 2021, 204:1143-52. 10.1164\/rccm.202102-0289OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00287-2025","article-title":"The effect of different inhaled corticosteroid and long-acting bronchodilator combinations on the airway microbiome in patients with severe COPD: a randomised trial (MUSIC)","volume":"66","author":"Richardson H","year":"2025","unstructured":"Richardson H, Alferes De Lima Headley D, Clarke C, et al.. The effect of different inhaled corticosteroid and long-acting bronchodilator combinations on the airway microbiome in patients with severe COPD: a randomised trial (MUSIC). Eur Respir J. 2025, 66:2500287. 10.1183\/13993003.00287-2025","journal-title":"Eur Respir J"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1265544","article-title":"Prevention of exacerbation in patients with moderate-to-very severe COPD with the intent to modulate respiratory microbiome: a pilot prospective, multi-center, randomized controlled trial","volume":"10","author":"Hua JL","year":"2023","unstructured":"Hua JL, Yang ZF, Cheng QJ, et al.. Prevention of exacerbation in patients with moderate-to-very severe COPD with the intent to modulate respiratory microbiome: a pilot prospective, multi-center, randomized controlled trial. Front Med (Lausanne). 2023, 10:1265544. 10.3389\/fmed.2023.1265544","journal-title":"Front Med (Lausanne)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-025-03733-7","article-title":"Characterizing gut microbial dysbiosis and exploring the effect of prebiotic fiber supplementation in patients with COPD","volume":"64","author":"van Iersel LE","year":"2025","unstructured":"van Iersel LE, Beijers RJ, Simons SO, et al.. Characterizing gut microbial dysbiosis and exploring the effect of prebiotic fiber supplementation in patients with COPD. Eur J Nutr. 2025, 64:210. 10.1007\/s00394-025-03733-7","journal-title":"Eur J Nutr"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2018.11.003","article-title":"Contamination in low microbial biomass microbiome studies: issues and recommendations","volume":"27","author":"Eisenhofer R","year":"2019","unstructured":"Eisenhofer R, Minich JJ, Marotz C, Cooper A, Knight R, Weyrich LS. Contamination in low microbial biomass microbiome studies: issues and recommendations. Trends Microbiol. 2019, 27:105-17. 10.1016\/j.tim.2018.11.003","journal-title":"Trends Microbiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-025-02035-2","article-title":"Guidelines for preventing and reporting contamination in low-biomass microbiome studies","volume":"10","author":"Fierer N","year":"2025","unstructured":"Fierer N, Leung PM, Lappan R, et al.. Guidelines for preventing and reporting contamination in low-biomass microbiome studies. Nat Microbiol. 2025, 10:1570-80. 10.1038\/s41564-025-02035-2","journal-title":"Nat Microbiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99127-w","article-title":"Lung microbiome of stable and exacerbated COPD patients in Tshwane, South Africa","volume":"11","author":"Goolam Mahomed T","year":"2021","unstructured":"Goolam Mahomed T, Peters RP, Allam M, et al.. Lung microbiome of stable and exacerbated COPD patients in Tshwane, South Africa. Sci Rep. 2021, 11:19758. 10.1038\/s41598-021-99127-w","journal-title":"Sci Rep"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00595-2023","article-title":"Sputum microbiome \u03b1-diversity is a key feature of the COPD frequent exacerbator phenotype","volume":"10","author":"Pragman AA","year":"2024","unstructured":"Pragman AA, Hodgson SW, Wu T, Zank A, Reilly CS, Wendt CH. Sputum microbiome \u03b1-diversity is a key feature of the COPD frequent exacerbator phenotype. ERJ Open Res. 2024, 10:00595-2023. 10.1183\/23120541.00595-2023","journal-title":"ERJ Open Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2020.04.023","article-title":"Consensus document on the diagnosis and treatment of chronic bronchial infection in chronic obstructive pulmonary disease","volume":"56","author":"de la Rosa Carrillo D","year":"2020","unstructured":"de la Rosa Carrillo D, L\u00f3pez-Campos JL, Alc\u00e1zar Navarrete B, et al.. Consensus document on the diagnosis and treatment of chronic bronchial infection in chronic obstructive pulmonary disease. Arch Bronconeumol (Engl Ed). 2020, 56:651-64. 10.1016\/j.arbres.2020.04.023","journal-title":"Arch Bronconeumol (Engl Ed)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/525299-a-narrative-review-of-airway-and-gut-microbiota-in-chronic-obstructive-pulmonary-disease-clinical-associations-methodological-heterogeneity-and-translational-priorities","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:03:03Z","timestamp":1788422583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/525299-a-narrative-review-of-airway-and-gut-microbiota-in-chronic-obstructive-pulmonary-disease-clinical-associations-methodological-heterogeneity-and-translational-priorities"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.115698","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,3]]}}}